SITC 2018 Abstract Titles

The Society for Immunotherapy of Cancer's (SITC) 33^rd Annual Meeting received a record-breaking number of abstracts. Researchers submitted nearly 800 abstracts!

All accepted abstracts are published in the SITC 2018 Abstract Book as well as in two Journal for ImmunoTherapy of Cancer (JITC) supplements, published on Nov. 6 (regular abstracts) and Dec. 6 (late-breaking abstracts).

Click the following links to access the abstracts:

• SITC 2018 Abstract Book (PDF)
• Nov. 6 JITC Supplement (regular abstracts)
• Dec. 6 JITC Supplement (late-breaking abstracts)

Titles for abstracts submitted to the Society for Immunotherapy of Cancer's (SITC) 33^rd Annual Meeting are available!

Click the various abstract categories further below to begin browsing titles of the newest research unveiled at SITC 2018.

• Biomarkers and Immune Monitoring
• Cancer Vaccines, Personalized Vaccines and Technologies/Personalized Medicine
• Cellular Metabolism and Antitumor Immunity
• Cellular Therapy Approaches
• Clinical Trials (Completed)
• Clinical Trials (In Progress)
• Combination Therapy (IO/IO, IO/Standard of Care, IO/Other)
• Co-Stimulatory Ligand-Receptor Interactions
• Cytokines in Anti-Tumor Immunity
• Direct Antibody Mediated Anti-Tumor Activity (ADCC/CDC) and Antibody-Directed Conjugates
• Emerging Models and Imaging
• Immune Effects of Chemotherapy, Radiation and Targeted Therapies
• Immunosuppressive Cells in the Tumor Microenvironment
• Impact of Diet, Exercise, and/or Stress on Antitumor Immunity
• Innate Anti-Tumor Immunity (NK cells, monocytes, macrophages, etc.)
• Mechanisms of Resistance to Immunotherapy
• Mechanisms of Toxicity
• Microbiome and Anti-Tumor Immunity or I-O Agent Toxicity
• Micro-RNA, Epigenetics and Tumor/Immune-cell Signaling Pathways in Anti-Tumor Immunity
• Oncogenetics and Immunogenomics
• Oncolytic Viruses and Intratumoral Therapies
• Other
• T-cell Checkpoints and Checkpoint Inhibitors